Chronic Wounds
Fibroblast technology developed for diabetic foot ulcers, chronic wounds
FibroBiologics and Charles River have announced the completion of FibroBiologics’ master cell bank for a product that will be evaluated for the treatment of diabetic foot ulcers and other chronic wounds, according to a press release.
FDA clears first antimicrobial wound dressing with integrated lidocaine for painful wounds
The FDA has issued a 510(k) clearance to Imbed Biosciences to market Microlyte Ag/Lidocaine for the management of painful skin wounds, the company announced in a press release.
FDA grants BPGbio rare pediatric disease designation for epidermolysis bullosa treatment
The FDA granted rare pediatric disease designation for BPM31510T for the treatment of epidermolysis bullosa, BPGbio announced in a press release.
Bromelain-based enzymatic debridement agent rapidly treats venous leg ulcer wounds
A new bromelain-based enzymatic debridement product was effective at rapidly debriding venous leg ulcer wounds without pain, according to this study.
Smith & Nephew launches negative pressure wound therapy system
Smith & Nephew announced the launch of its Renasys Edge negative pressure wound therapy system for patients with chronic wounds, according to a company press release.